Task: Answer the multiple choice question.
Question: Which compound exhibits a -1.220% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COc1ccccc1N1CCN(C(=O)c2ccc(NC(C)=O)cc2)CC1
b COc1ccc(C(=O)NCc2nnc(SCC(=O)N3CCCc4ccccc43)o2)cc1OC
Answer: b. COc1ccc(C(=O)NCc2nnc(SCC(=O)N3CCCc4ccccc43)o2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C(=O)NCc2nnc(SCC(=O)N3CCCc4ccccc43)o2)cc1OC
COc1ccc(C(=O)NCc2nnc(SCC(=O)N3CCCc4ccccc43)o2)cc1OC
N-[[5-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]sulfanyl-1,3,4-oxadiazol-2-yl]methyl]-3,4-dimethoxybenzamide